Opinion: Enough pink: We’re doing Breast Cancer Awareness Month all wrong
October is upon us, which means the world is about get a whole lot more…
Author: STAT
STAT+: Three generic drug makers to pay $450 million to settle criminal price fixing charges
Three generic drug makers agreed to pay nearly $450 million to resolve civil allegations that…
For the first time, WHO committee recommends action on high-priced essential medicines
For the first time, a World Health Organization committee has recommended the global agency form…
STAT+: Prosecutors allege two individuals preyed on those searching for addiction recovery help
Two men were indicted this week for allegedly running a scam in which they preyed…
STAT+: Pharmalittle: Merck’s Covid-19 pill reduced hospitalizations in a study; Dems start scaling back drug-pricing plans
And so, another working week will soon draw to a close. Not a moment too…
Merck’s antiviral pill reduces hospitalization of Covid patients, a possible game-changer for treatment
An investigational antiviral pill reduced the chances that patients newly diagnosed with Covid-19 would be…
Opinion: For abortion care, physicians may need to step aside to support patients
I have come to think that people who provide abortion care are models of the…
.jpg)
STAT+: In the ‘fail fast’ world of biotech, ‘offboarding’ is just as important as onboarding
In today’s biotech job market — where competition for people with in-demand experience is fiercer…
STAT+: Why the medical AI company Dascena hopes hard evidence will separate it from its rivals
Think of it as digital health’s chicken and egg problem. Which comes first: national distribution…
A new surgical robot is smaller, nimbler, and cheaper, its maker claims. But will it be better for patients?
The surgical robot market, long dominated by one company, has a new entrant hoping to…
STAT+: Biden administration favors insurers over doctors in controversial new surprise billing regulations
WASHINGTON — The Biden administration on Thursday sided with insurers over physicians and other health…
Listen: Health equity ‘tourism,’ an $11B biopharma acquisition, & a bony Covid protest
An $11 billion biopharma acquisition. Health equity “tourism.” And, where can you buy a 12-foot…
STAT+: Genetic information can be messy. Mapping proteins could offer a clearer view of what’s driving cancer
Scientists have unveiled new maps of the protein networks underlying different types of cancer, offering…
STAT+: Key Senate committee considers a carveout for small biotech companies in drug pricing reforms
WASHINGTON — A key Senate panel is seriously considering a new policy that would soften…
STAT+: Appeals court rules FDA ‘arbitrarily and capriciously’ approved a rare disease drug
In a closely watched battle over regulatory decision-making, a federal appeals court ruled the U.S….
Who telehealth isn’t reaching & Apple looks past A-fib
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: With $11 billion Acceleron deal, new Merck CEO hopes to convince investors there is a lot more to the biopharma giant
Merck will continue to search out more acquisitions after its $11 billion purchase of biotech…
Virtual Event: The evolving landscape for biosimilars
Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET….
STAT+: Pharmalittle: House panel OKs bills to halt pharma practices that raise prices; Merck to buy Acceleron for $11.5 billion
Rise and shine, everyone, another busy day is on the way. This morning is getting…
Opinion: Repurposing drugs can speed new treatments for Covid-19
As the summer of 2021 started to unfold, many Americans thought the pandemic was beginning…
Opinion: Covid-19 has revealed the hazards of blocking physician-owned hospitals
Covid-19 caught the U.S. flatfooted. With supply shortages, the availability of intensive care unit beds,…
Telehealth has rapidly expanded. But companies are still struggling to reach rural populations
Despite the wide-ranging expansion of telehealth in the past year, there is still a broad…
A new study points to the power of wearables to predict even presymptomatic infections, suggesting use one day against Covid-19
A new study that infected willing participants with common cold and flu viruses provides the…
STAT+: Pharmalittle: Run on ivermectin tablets leaves less for livestock; Pfizer Covid-19 shot for kids may not come until November
Hello, everyone, and welcome to the middle of the week. You made it this far,…
STAT+: Editas CRISPR treatment improved vision for one patient, but not others, early data show
An experimental CRISPR-based treatment from Editas Medicine led to meaningful improvements in the functional vision…
STAT+: As lawsuits mounted, Purdue cultivated conversations with a controversial addiction policy group
Over several months in 2017, a top Purdue Pharma executive and the head of the…
Opinion: Listen: Revisiting Uché Blackstock on leaving academic medicine
This week, “First Opinion Podcast” returns to a conversation with emergency physician Uché Blackstock about…
Opinion: Overdose prevention sites can save lives and promote recovery. We must be willing to try them
The latest statistics from the Centers for Disease Control and Prevention (CDC) are simply staggering:…
Watch: The tedious process of training computers to think, explained
Artificial intelligence may seem like some amorphous, all-knowing entity that could outperform humans at even…
STAT+: Lilly cuts the wholesale price on some insulin products, but impact is likely to be limited
Eli Lilly (LLY) announced plans to lower the wholesale price of certain insulin products by…
STAT+: FDA tells drug makers to redo studies run by two contract research firms due to data integrity issues
In a rare move, the U.S. Food and Drug Administration has notified an untold number…
The government’s Covid-19 response will continue in a shutdown, but health agencies will face major staff shortages
A version of this story first appeared in D.C. Diagnosis, STAT’s weekly newsletter about the…
Side effect rates from a third Covid-19 vaccine dose similar to those after second shot, early data indicate
People who’ve received a third dose of a Covid-19 vaccine are reporting rates of side…
Behind Epic’s algorithm to detect sepsis before it progresses
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: Sanofi ends work on mRNA Covid-19 vaccine; Biogen seeks fast FDA approval of another Alzheimer’s drug
Top of the morning to you. And a fine one it is. Crystal clear blue…
STAT+: STAT+ Conversation: How medicine’s biggest journals are confronting racism
Editor’s note: A livestream of the conversation will be embedded below at 1 p.m. ET….
STAT+: Graduate students launch an entrepreneurship program to bring new faces to biotech
A group of graduate students is expanding a Boston-based biotech entrepreneurship program across the country,…
STAT+: Biogen, Eisai seek fast approval for second Alzheimer’s drug, relying on relaxed FDA standard
Biogen and its Japanese partner Eisai announced Monday evening the start of an application process…
.jpg)
Opinion: Paying participants isn’t the way to improve clinical trial recruitment
It’s notoriously difficult to recruit people to participate in clinical trials. It’s even harder to…
STAT+: Big business lobbies bitterly divided over drug pricing reform
WASHINGTON — Groups representing companies like Apple, Tesla, and Boeing are clashing with Washington’s wealthiest…
With positive data on mRNA Covid vaccine, Sanofi sets its sights on other pathogens
French vaccine giant Sanofi announced positive results of a Phase 1/2 clinical trial of its…
The Biden administration wants scientific advisers. It just doesn’t like what they have to say
Over the past month, the United States public has received a booster dose of confusion….
STAT+: Inflation and rebates caused wholesale prices on medicines to drop in second quarter
Amid continued political pressure on the pharmaceutical industry, a new analysis finds brand-name drug makers…
STAT+: Pharmalittle: Moderate House Dems’ opposition to drug-pricing reforms shrinks; Glaxo goes on charm offensive
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
Opinion: Building resilience and well-being: keys to avoiding the worst of a looming shortage of health care workers
During the marathon of Covid-19, nurses and other health care workers have faced unprecedented levels…
Opinion: I fear Covid-19 is pushing young physicians out of medicine
During more than 30 years as a physician and an officer in the U.S. Air…
STAT+: In May, 10 moderate Democrats opposed major drug pricing reform. Ahead of a key vote, that list is shrinking
WASHINGTON — Ten House Democrats fired a warning shot in the spring that they could…
STAT+: Epic’s sepsis algorithm is going off the rails in the real world. The use of these variables may explain why
In marketing materials and internal documents, national electronic health record vendor Epic Systems has touted…
STAT+: WHO adds Regeneron drug to recommended Covid-19 treatments, but criticizes its pricing
The World Health Organization added a Regeneron Pharmaceuticals medication to its list of recommended treatments…
Biden’s chaotic messaging on Covid-19 boosters is pitting the White House against the government’s scientific advisers
WASHINGTON — The White House’s chaotic, contradictory messaging on Covid-19 vaccine booster shots has given…